2022 annual financial data
Innate Pharma 2022 Net margin
Innate Pharma 2022 net margin with verified reported values.
Direct answer
Net margin was -100.74%.
Operating income was -57,425,000 EUR and net income was -58,103,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,674,000 EUR
- Operating income
- -57,425,000 EUR
- Net income
- -58,103,000 EUR
- Operating cash flow
- Not available